Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies
Year: 2015
Type: review
Abstract: Mitochondrial diseases are severe and largely untreatable. Owing to the many essential processes carried out by mitochondria and the complex cellular systems that support these processes, these diseases are diverse, pleiotropic, and challenging to study. Much of our current understanding of mitochondrial function and dysfunction comes from studies in the baker's yeast Saccharomyces cerevisiae. Because of its good fermenting capacity, S. cerevisiae can survive mutations that inactivate oxidative phosphorylation, has the ability to tolerate the complete loss of mitochondrial DNA (a property referred to as 'petite-positivity'), and is amenable to mitochondrial and nuclear genome manipulation. These attributes make it an excellent model system for studying and resolving the molecular basis of numerous mitochondrial diseases. Here, we review the invaluable insights this model organism has yielded about diseases caused by mitochondrial dysfunction, which ranges from primary defects in oxidative phosphorylation to metabolic disorders, as well as dysfunctions in maintaining the genome or in the dynamics of mitochondria. Owing to the high level of functional conservation between yeast and human mitochondrial genes, several yeast species have been instrumental in revealing the molecular mechanisms of pathogenic human mitochondrial gene mutations. Importantly, such insights have pointed to potential therapeutic targets, as have genetic and chemical screens using yeast.
Source: Disease Models & Mechanisms
DOI: 10.1242/dmm.020438
Authors: Jean-Paul Lasserre, Alain Dautant, Raeka S. Aiyar, Roza Kucharczyk, Annie Glatigny, Déborah Tribouillard-Tanvier, Joanna Rytka, Marc Blondel, Natalia Skoczen, Pascal Reynier, Laras Pitayu, Agnès Rötig, Agnès Delahodde, Lars M. Steinmetz, Geneviève Dujardin, Vincent Procaccio, Jean-Paul di Rago
Institutions: Centre National de la Recherche Scientifique, Institut de Biochimie et Génétique Cellulaires, European Molecular Biology Laboratory, European Molecular Biology Laboratory, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Polish Academy of Sciences, Université Paris-Sud, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Université Paris-Saclay, CEA Paris-Saclay - Etablissement de Saclay, Institut de Biologie Intégrative de la Cellule, CEA Paris-Saclay, Inserm, Université de Bretagne Occidentale, Établissement Français du Sang, Centre Hospitalier Régional Universitaire de Brest, Génétique, Génomique Fonctionnelle et Biotechnologies, Centre Hospitalier Universitaire d'Angers, Hôpital Necker-Enfants Malades, Sorbonne Paris Cité, Institut des Maladies Génétiques Imagine, Université Paris Descartes, Stanford Medicine, Stanford University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,750
OpenAlex ID: W2122034403
